Malaria Vaccine Candidate Demonstrates Overall Efficacy Of 75% In Young Children With No Serious Safety Concerns, Trial Shows
November 04, 2022
MedPage Today (11/3, Hein) reports the malaria vaccine candidate R21/Matrix-M “demonstrated an overall efficacy of 75% in young children, and with no serious safety concerns, results from a phase III trial spanning four African nations showed.” In “modifi...